Guangdong Xiongsu Technology Group
300599
BOE HC SemiTek Corporation
300323
Sichuan Chuanhuan Technology
300547
Suzhou Industrial Park Heshun Electric
300141
Toyou Feiji Electronics
300302
CN Stock MarketDetailed Quotes
601628 China Life Insurance
- 42.08
- -0.62-1.45%
Trading Dec 27 10:15 CST
1.19TMarket Cap13.60P/E (TTM)
43.00High41.85Low36.73KlotVolume42.69Open42.70Pre Close155.40MTurnover0.02%Turnover Ratio56.33P/E (Static)28.26BShares50.6852wk High2.12P/B876.25BFloat Cap24.4652wk Low46.97Limit Up20.82BShs Float68.80Historical High38.43Limit Down2.69%Amplitude7.82Historical Low0.63Dividend TTM42.31Avg Price20.74KlotAsk1.50%Div YieldTTM100Lot Size13.95KlotBid
China Life Insurance Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Premiums received from original insurance contracts | 2.55%679.57B | 7.59%514.02B | 7.81%324.93B | 3.52%639.67B | 34.02%662.66B | 30.83%477.78B | 28.23%301.4B | 0.21%617.9B | 2.04%494.46B | 0.42%365.18B |
| Net cash received from reinsurance business | --215M | -39.29%136M | ---- | ---- | ---- | --224M | --20M | ---- | ---- | ---- |
| Net increase in deposits from policyholders | ---- | ---- | ---- | 98.87%94.38B | ---- | ---- | ---- | 267.38%47.46B | 221.93%38.44B | 192.45%27.42B |
| Cash received relating to other operating activities | 12.55%9.1B | 1.31%7.48B | 6.10%5.55B | -36.80%11.28B | -37.95%8.09B | -35.03%7.38B | 57.96%5.23B | 23.85%17.86B | 34.86%13.04B | 93.77%11.36B |
| Special items of operating cash inflws | ---- | --91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from operating activities | 2.70%688.89B | 7.49%521.73B | 7.77%330.48B | 8.59%745.33B | 22.44%670.75B | 19.58%485.38B | 16.51%306.65B | 6.59%686.39B | 8.16%547.8B | 5.86%405.89B |
| Staff behalf paid | -5.77%18.66B | -5.74%12.26B | -4.59%5.88B | -1.83%25.84B | -2.03%19.8B | -6.26%13.01B | -5.21%6.17B | 9.13%26.32B | 10.23%20.21B | 8.99%13.88B |
| All taxes paid | 6.17%5.2B | 20.33%3.53B | -10.11%1.27B | -7.16%5.78B | -10.73%4.89B | -20.37%2.93B | -33.97%1.42B | -48.46%6.23B | -59.88%5.48B | -65.47%3.68B |
| Cash paid for fees and commissions | -6.22%51.1B | -3.00%37.81B | -2.83%21.61B | 13.48%62.88B | 17.51%54.49B | 11.41%38.98B | 2.55%22.24B | -17.79%55.41B | -17.40%46.37B | -18.29%34.99B |
| Cash paid for indemnity of original insurance contract | 14.19%251.06B | 15.87%175.57B | 19.66%109.2B | 25.28%217.72B | 65.24%219.87B | 71.47%151.53B | 85.77%91.26B | -1.41%173.78B | -2.35%133.07B | -5.24%88.37B |
| Net cash for reinsurance | ---- | ---- | --24M | -62.12%486M | -60.64%416M | ---- | ---- | 35.34%1.28B | 105,600.00%1.06B | 250.68%519M |
| Policy dividend cash paid | ---- | ---- | ---- | -8.07%19.88B | ---- | ---- | ---- | -9.98%21.62B | -7.78%17.8B | -7.24%11.68B |
| Net increase in financial assets held for trading purposes | ---- | ---- | ---- | -98.48%413M | ---- | ---- | ---- | --27.14B | ---- | ---- |
| Cash paid relating to other operating activities | -20.50%12.5B | -10.97%12.01B | -22.80%5.71B | -3.18%21.92B | -19.49%15.73B | 34.11%13.49B | 44.24%7.39B | -13.65%22.64B | 22.45%19.53B | -5.52%10.06B |
| Special items of operating cash outflws | -73.80%3.77B | ---- | 37.62%3.03B | ---- | --14.4B | --8.78B | --2.2B | ---- | ---- | ---- |
| Cash outflows from operating activities | -1.01%342.28B | 2.21%241.17B | 12.29%146.72B | 6.78%357.1B | 33.52%345.77B | 44.60%235.96B | 47.11%130.67B | -6.45%334.42B | -0.43%258.97B | -11.84%163.18B |
| Net cash flows from operating activities | 6.65%346.6B | 12.48%280.55B | 4.42%183.76B | 10.30%388.23B | 12.52%324.98B | 2.76%249.42B | 0.92%175.98B | 22.87%351.97B | 17.23%288.83B | 22.39%242.71B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 73.05%1.7T | 58.71%1.1T | 45.72%531.12B | 3.71%1.2T | 5.31%979.94B | 24.10%690.72B | 5.00%364.49B | 67.27%1.16T | 89.90%930.54B | 82.14%556.57B |
| Cash received from returns on investments | -2.21%133.76B | -1.78%88.87B | -12.89%36.38B | 2.07%191.41B | 1.70%136.78B | 2.87%90.48B | -8.27%41.77B | 7.47%187.52B | 10.76%134.5B | 14.59%87.95B |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -47.06%45M | 46.27%98M | 155.00%51M | 189.53%1.05B | -42.57%85M | -32.32%67M | -25.93%20M | 6.45%363M | -40.08%148M | -59.43%99M |
| Net cash received from disposal of subsidiaries and other business units | --5.45B | --2.9B | 510.00%183M | ---- | ---- | ---- | --30M | 686.23%4.4B | -46.99%255M | ---- |
| Special items of investing cash inflows | ---- | ---- | --4.86B | --21.84B | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 64.31%1.84T | 52.08%1.19T | 40.93%572.6B | 4.81%1.42T | 4.82%1.12T | 21.20%781.26B | 3.47%406.31B | 55.64%1.35T | 74.04%1.07T | 68.49%644.63B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 28.22%2.52B | 121.27%2.57B | 128.95%1.65B | 35.60%4.17B | 14.36%1.97B | -14.44%1.16B | 30.32%722M | -44.90%3.08B | -44.64%1.72B | -38.93%1.36B |
| Cash paid to acquire investments | 52.06%2.13T | 49.31%1.38T | 22.04%569.69B | 24.90%1.79T | 29.75%1.4T | 27.00%923.59B | 36.19%466.81B | 21.23%1.43T | 25.22%1.08T | 27.18%727.22B |
| Net cash paid to acquire subsidiaries and other business units | -6.71%10.27B | -6.56%7.25B | -37.06%1.23B | -2.01%34.04B | -9.17%11.01B | -32.70%7.76B | 1,436.22%1.95B | -3.28%34.74B | -7.50%12.12B | -11.73%11.53B |
| Impawned loan net increase | ---- | ---- | ---- | -11.64%16.08B | ---- | ---- | ---- | -48.71%18.2B | -51.83%12.92B | -55.69%9.25B |
| Net increase in resale business funds (investment) | --6.17B | -64.43%5.56B | ---- | ---- | ---- | -51.14%15.62B | -92.36%2.24B | 874.57%27.33B | 67.45%12.87B | 2,265.31%31.98B |
| Cash paid relating to other investing activities | ---- | ---- | ---- | --198M | --198M | --20M | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 51.98%2.15T | 47.07%1.39T | 21.38%572.57B | 21.63%1.85T | 26.33%1.41T | 21.35%948.16B | 24.66%471.72B | 20.17%1.52T | 22.60%1.12T | 28.23%781.34B |
| Net cash flows from investing activities | -5.79%-315.47B | -23.61%-206.3B | 100.04%28M | -159.53%-428.1B | -445.97%-298.19B | -22.08%-166.9B | -557.69%-65.41B | 58.12%-164.96B | 81.88%-54.62B | 39.70%-136.71B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -42.09%10.36B | 17.43%12.73B | 22.05%8.57B | 205.89%18.04B | 451.96%17.89B | --10.84B | --7.02B | -74.20%5.9B | -81.28%3.24B | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -42.09%10.36B | 17.43%12.73B | 22.05%8.57B | 205.89%18.04B | 451.96%17.89B | --10.84B | --7.02B | -74.20%5.9B | -81.28%3.24B | ---- |
| Cash from bonds issue | --35B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -22.22%14M | ---- | ---- | -93.75%43M | --18M | --18M | --18M | 493.10%688M | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | --750M | --750M | --750M | --750M | ---- | ---- | ---- |
| Net increase in repurchase funds (fundraising) | ---- | ---- | ---- | --67.13B | --5.48B | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 87.97%45.37B | 9.66%12.73B | 10.02%8.57B | 1,205.54%85.96B | 644.80%24.14B | --11.61B | --7.79B | -95.30%6.58B | -96.10%3.24B | ---- |
| Borrowing repayment | 6,139.25%35.13B | 6,429.18%35.13B | 25,079.86%35B | -93.03%577M | 480.41%563M | 627.03%538M | 101.45%139M | 75,127.27%8.28B | --97M | --74M |
| Dividend interest payment | -6.86%18.76B | 12.39%5.54B | -4.43%3.17B | -15.91%22.19B | -17.56%20.14B | -6.37%4.93B | 6.93%3.32B | -1.10%26.39B | -3.83%24.43B | 17.65%5.26B |
| Cash payments relating to other financing activities | -0.13%760M | 2.06%496M | 11.39%264M | 123.26%2.92B | -38.03%761M | -83.85%486M | -93.87%237M | -42.35%1.31B | -33.80%1.23B | 108.96%3.01B |
| Cash outflows from financing activities | 597.19%149.64B | 439.29%146.35B | 17.98%86.21B | -79.73%25.68B | -87.92%21.46B | -62.58%27.14B | -56.17%73.07B | 337.46%126.68B | 551.59%177.6B | 1,127.02%72.53B |
| Net cash flows from financing activities | -3,996.26%-104.26B | -760.48%-133.62B | -18.93%-77.64B | 150.19%60.27B | 101.53%2.68B | 78.59%-15.53B | 60.85%-65.28B | -207.98%-120.1B | -411.95%-174.36B | -235.36%-72.53B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -128.04%-30M | -91.23%10M | 136.11%13M | -70.51%64M | -53.07%107M | -44.39%114M | -28.57%-36M | 405.63%217M | 860.00%228M | 639.47%205M |
| Net increase in cash and cash equivalents | -347.38%-73.16B | -188.44%-59.36B | 134.61%106.16B | -69.51%20.47B | -50.77%29.57B | 99.29%67.11B | 106.56%45.25B | 1,687.88%67.14B | 7,018.25%60.08B | 33.94%33.68B |
| Add:Begin period cash and cash equivalents | 16.04%148.06B | 16.04%148.06B | 16.04%148.06B | 111.04%127.59B | 111.04%127.59B | 111.04%127.59B | 111.04%127.59B | 6.62%60.46B | 6.71%60.46B | 6.71%60.46B |
| End period cash equivalent | -52.34%74.9B | -54.44%88.7B | 47.08%254.22B | 16.04%148.06B | 30.39%157.17B | 106.84%194.71B | 109.85%172.84B | 111.04%127.59B | 109.63%120.54B | 15.08%94.14B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.